Stephanie Hsieh, J.D., M.B.A.
President and CEO

Ms. Hsieh has a proven track record of setting and executing on value-building corporate strategies, particularly strategic patent portfolios.

Most recently, she held a senior position at Impax Laboratories, Inc., working with both the generic and specialty pharma divisions, leading cross-functional teams on crafting and executing on business and product strategies, including negotiating key marketing, licensing and development agreements with several major pharmaceutical companies.

Over her career she has helped devise strategies for the protection and lifecycle management of branded products, consulted to life science companies and entrepreneurs on business and patent strategies, as well as managed and prosecuted patent portfolios.

Ms. Hsieh received her M.B.A. from Stanford University and J.D. from Columbia University where she was a Harlan Fiske Stone Scholar. She received her B.A. in Biological Chemistry from Wellesley College where she graduated magna cum laude and phi beta kappa.

Elisabeth Gardiner, Ph.D.
Chief Scientific Officer

Dr. Gardiner is a seasoned scientific officer having led a number of drug discovery efforts, managing the design and execution of numerous external studies and collaborations.

She previously served as director of physiology discovery at aTyr Pharma where she managed the in vivo and vitro assay development groups. Prior to aTyr, she was associate director of high-throughput screening at the Genomics Institute of the Novartis Research Foundation. Dr. Gardiner also held a variety of positions at Kalypsys, Inc., where she led multiple projects from screening through preclinical in vivo proof of concept.

Dr. Gardiner was a post-doctoral fellow at The Scripps Research Institute, where she studied inflammation and oncology targets. She has contributed to numerous peer-reviewed publications and is a co-inventor on a number of published patents. Dr. Gardiner received her Ph.D. from the University of Wisconsin-Madison and a M.S. and B.S. from Texas A&M University.

Robert P. McKenzie
Executive Vice President of Business Development

Bob McKenzie brings more than 25 years of experience in worldwide business development, as well as general and operational management expertise in sales and marketing, primarily in the technology industry.

Most recently, he was vice president at Amdocs, a global leader in outsourced business services, where he oversaw key global accounts in the company's Broadband, Cable and Satellite division, and was responsible for strategic planning in the cable and satellite industry, product development, business development and program delivery.

Mr. McKenzie is an internationally recognized business development professional, having orchestrated billion-dollar, transnational deals within the telecom and media industries.

He earned his B.A. in Business Economics from the University of California at Santa Barbara and serves on the board of Stanford Youth Solutions.

Carving a New Space

Learn about how our SnAP technology creates a unique binding site within the Fab region that adds functionality to monoclonal antibodies.

» Learn More